Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jones Lang LaSalle Inc (JLL) vs Kenvue Inc. Common Stock (KVUE) Price & Performance

Jones Lang LaSalle IncTrade
Kenvue Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Jones Lang LaSalle Inc vs Kenvue Inc. Common Stock — how do they compare? Jones Lang LaSalle Inc trades at $299.87 (market cap $13.95B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 2.4× Jones Lang LaSalle Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.

JLLKVUE
Market Cap
$13.95B$34.06B
Volume
457,46223,267,228
Sector
Real EstateConsumer Staples
52-Week High
$392.79$19.83
52-Week Low
$280.16$14.11
Typical Hold Time
71 Days—
Enterprise Value
$16.71B$41.56B
Dividend Yield
—4.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Jones Lang LaSalle Inc

JLL trades at $299.87, up 1.08% today, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q2 2026 EPS of $5.26 exceeding the $4.56 estimate. Revenue grew to $26.12B in 2025, and net income margin improved to 3.64%. Recent news highlights acquisitions and financing deals, such as the $406M Trammell Crow Center financing announced on September 24, 2026.

The outlook is positive, supported by analyst consensus price target of $450.50 and 58.33% buy ratings. Key opportunities include growth in data center operations and proprietary platforms, while risks involve real estate market volatility and competitive pressures. The stock offers value with a P/E of 14.54 and P/S of 0.53, but investors should monitor debt levels and economic cycles.

Kenvue Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JLL
100% Buy0% Sell
Avg holding period · 71 Days
KVUE

No sentiment data available yet.

Top news

Latest headlines on both assets

About Jones Lang LaSalle Inc

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.

Read more on JLL →

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →